Prescription drug · NDA
XYLOCAINE- MPF (LIDOCAINE HCl ) (Lidocaine hcl) NDC 51662-1604
Lidocaine hydrochloride anhydrous 20 mg/mL · Injection, Solution · Epidural, Infiltration, Intracaudal, Perineural · HF Acquisition Co LLC, DBA HealthFirst
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51662-1604-3 | 5166216040351662160403 | 25 POUCH in 1 CASE (51662-1604-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1604-2) / 5 mL in 1 VIAL, SINGLE-DOSEMarketed from Sep 15, 2022 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- XYLOCAINE- MPF (LIDOCAINE HCl )
- Generic name (nonproprietary)
- lidocaine hcl
- Active ingredients
- Lidocaine hydrochloride anhydrous — 20 mg/mL
- Dosage form
- Injection, Solution
- Route
- Epidural, Infiltration, Intracaudal, Perineural
- Labeler
- HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 006488
- Marketing start
- Listing expires
- Other FDA classes
- Amides (Chemical structure)Local Anesthesia (Physiologic effect)
- Identifiers
- Product ID 51662-1604_0ffaa292-6882-199f-e063-6294a90ac7c4SPL ID 0ffaa292-6882-199f-e063-6294a90ac7c4SPL set ID e8b987c8-b5cb-74cd-e053-2a95a90a5a93RxCUI 1737761, 1737762UNII EC2CNF7XFPUPC 0363323495046
- Pharmacologic class
- Amide Local Anesthetic; Antiarrhythmic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N451662160403followed by a unit qualifier and the quantityPackage 51662-1604-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS & USAGE Xylocaine (lidocaine HCl) Injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed.
Excerpt only. Read the full label for complete information.
About NDC 51662-1604
- What is NDC 51662-1604?
- 51662-1604 is the product NDC for XYLOCAINE- MPF (LIDOCAINE HCl ) (lidocaine hcl), Lidocaine hydrochloride anhydrous 20 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- XYLOCAINE- MPF (LIDOCAINE HCl ) (LIDOCAINE HCl).
- What is the active ingredient?
- Lidocaine hydrochloride anhydrous.
- Who is the labeler?
- HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for XYLOCAINE- MPF (LIDOCAINE HCl )?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Other NDCs under NDA 006488
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Xylocainelidocaine hydrochloride and epinephrine | Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .005 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | Henry Schein, Inc. | 0404-9972 |
| Xylocaine | Epinephrine bitartrate .01 mg/mL; Lidocaine hydrochloride anhydrous 10 mg/mL | Injection, SolutionInfiltration, Perineural | HF Acquisition Co LLC, DBA HealthFirst | 51662-1622 |
| Xylocainelidocaine hydrochloride,epinephrine bitartrate | Lidocaine hydrochloride anhydrous 10 mg/mL; Epinephrine bitartrate .01 mg/mL | Injection, SolutionInfiltration, Perineural | Fresenius Kabi USA, LLC | 63323-482 |
| Xylocainelidocaine hydrochloride,epinephrine bitartrate | Lidocaine hydrochloride anhydrous 5 mg/mL; Epinephrine bitartrate .005 mg/mL | Injection, SolutionInfiltration, Perineural | Fresenius Kabi USA, LLC | 63323-481 |
| Xylocainelidocaine hydrochloride | Lidocaine hydrochloride anhydrous 10 mg/mL | Injection, SolutionInfiltration, Perineural | Fresenius Kabi USA, LLC | 63323-485 |
| Xylocainelidocaine hydrochloride,epinephrine bitartrate | Lidocaine hydrochloride anhydrous 10 mg/mL; Epinephrine bitartrate .01 mg/mL | Injection, SolutionInfiltration, Perineural | Fresenius Kabi USA, LLC | 63323-482 |
| Xylocainelidocaine hydrochloride,epinephrine bitartrate | Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .01 mg/mL | Injection, SolutionInfiltration, Perineural | Fresenius Kabi USA, LLC | 63323-483 |
| Xylocainelidocaine hydrochloride | Lidocaine hydrochloride anhydrous 5 mg/mL | Injection, SolutionInfiltration, Perineural | Fresenius Kabi USA, LLC | 63323-484 |
| Xylocainelidocaine hydrochloride | Lidocaine hydrochloride anhydrous 10 mg/mL | Injection, SolutionInfiltration, Perineural | Fresenius Kabi USA, LLC | 63323-485 |
| Xylocainelidocaine hydrochloride | Lidocaine hydrochloride anhydrous 20 mg/mL | Injection, SolutionInfiltration, Perineural | Fresenius Kabi USA, LLC | 63323-486 |
| Xylocainelidocaine hydrochloride | Lidocaine hydrochloride anhydrous 20 mg/mL | Injection, SolutionInfiltration, Perineural | Fresenius Kabi USA, LLC | 63323-486 |
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 5 mg/mL | Injection, SolutionInfiltration | Fresenius Kabi USA, LLC | 63323-491 |
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 10 mg/mL; Epinephrine bitartrate .005 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | Fresenius Kabi USA, LLC | 63323-487 |
| Xylocaine MPFlidocaine hydrochloride,epinephrine bitartrate | Lidocaine hydrochloride anhydrous 15 mg/mL; Epinephrine bitartrate .005 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | Fresenius Kabi USA, LLC | 63323-488 |
| Xylocaine MPFlidocaine hydrochloride,epinephrine bitartrate | Lidocaine hydrochloride anhydrous 20 mg/mL; Epinephrine bitartrate .005 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | Fresenius Kabi USA, LLC | 63323-489 |
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 15 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | Fresenius Kabi USA, LLC | 63323-493 |
| Xylocaine Mpf | Lidocaine hydrochloride anhydrous 10 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | HF Acquisition Co LLC, DBA HealthFirst | 51662-1644 |
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 10 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | Fresenius Kabi USA, LLC | 63323-492 |
| Xylocaine | Lidocaine hydrochloride anhydrous 10 mg/mL | Injection, SolutionInfiltration, Perineural | HF Acquisition Co LLC, DBA HealthFirst | 51662-1645 |
| Xylocaine MPFlidocaine hydrochloride | Lidocaine hydrochloride anhydrous 10 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | Fresenius Kabi USA, LLC | 63323-492 |
Showing 20 of 39.